作为潜在的抗高血压药物,可溶性酸环酶刺激剂和激活剂作为潜在的抗高血压药物
Masashi Tawa1, Keisuke Nakagawa2, Mamoru Ohkita2
1Department of Pathological and Molecular Pharmacology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan. masashi.tawa@ompu.ac.jp.
概括
溶性酸环酶 (sGC) 激动剂在治疗高血压方面表现有前途. 这些刺激血管扩张的药物在各种临床前高血压模型中有效,支持其临床发展.
科学领域:
- 心血管药理学心血管药理学
- 高血压研究 高血压研究
背景情况:
- 高血压中血压控制不良需要新的治疗策略.
- 溶性甘酸环酶 (sGC) 是血管扩张中的关键酶,也是心血管疾病日益增长的治疗点.
研究的目的:
- 在各种临床前高血压模型中审查sGC激动剂的抗高血压作用.
- 为sGC激动剂在高血压治疗中的临床进步提供一个理由.
主要方法:
- 对sGC激动剂的临床前研究进行系统审查.
- 对各种高血压动物模型的疗效分析,包括自发性,盐敏感性和耐治疗形式.
主要成果:
- sGC刺激剂和激活剂通过不同的机制增强sGC活动.
- 临床前数据表明,sGC激动剂在多种模型中具有广泛的抗高血压疗效.
结论:
- sGC激动剂代表了对高血压管理的一类有前途的药物.
- 经过审查的证据强烈支持对高血压sGC激动剂的临床开发.
相关概念视频
Antihypertensive Drugs: Vasodilators
472
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
472
Antihypertensive Drugs: Angiotensin II Receptor Blockers
577
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
577
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
378
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
378
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
465
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
465
GPCRs Regulate Adenylyl Cylase Activity
5.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.2K


